Annual report
2928.TEDINET S100OLK7
Period2021-04-01 → 2022-03-31
Filed2022-06-29
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 150
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥162.4bn | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥168.6bn | 2020-04-01 → 2021-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥192.3bn | 2019-04-01 → 2020-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥209.7bn | 2018-04-01 → 2019-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥122.1bn | 2017-04-01 → 2018-03-31d | Cons. | Revenue IFRS (5-year summary) |
| Operating income | ¥5.2bn | 2021-04-01 → 2022-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥1.6bn | 2020-04-01 → 2021-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥3.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥525m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | −¥3.5bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | −¥11.5bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥10.3bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss before tax IFRS (5-year summary) |
| Net income (owners) | ¥2.1bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥1.6bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | −¥5.8bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | −¥19.5bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥9.1bn | 2017-04-01 → 2018-03-31d | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income | ¥3.7bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥1.9bn | 2020-04-01 → 2021-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥139.8bn | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥161.3bn | at 2021-03-31 | Cons. | Assets IFRS |
| Total assets | ¥182.7bn | at 2020-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥180.4bn | at 2019-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥174.3bn | at 2018-03-31d | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥103.7bn | at 2022-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥125.9bn | at 2021-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥36.1bn | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥35.4bn | at 2021-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥32.7bn | at 2020-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥26.6bn | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥26.8bn | at 2021-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥24.7bn | at 2020-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥42.3bn | at 2019-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥28.2bn | at 2018-03-31d | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥24.1bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥33.8bn | at 2021-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥27.0bn | at 2020-03-31d | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥42.2bn | at 2019-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Cash & equivalents | ¥43.6bn | at 2018-03-31d | Cons. | Cash and cash equivalents IFRS (5-year summary) |
| Operating cash flow | ¥10.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥24.9bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥14.6bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | −¥10.4bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥87m | 2017-04-01 → 2018-03-31d | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Investing cash flow | ¥2.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥20m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥3.4bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥7.7bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥3.5bn | 2017-04-01 → 2018-03-31d | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Financing cash flow | −¥22.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥18.2bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥28.3bn | 2019-04-01 → 2020-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥18.7bn | 2018-04-01 → 2019-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥22.7bn | 2017-04-01 → 2018-03-31d | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| EPS (basic) | ¥3.83 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥2.89 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥-10.48 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥-35.6 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥17.8 | 2017-04-01 → 2018-03-31d | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥3.83 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥2.89 | 2020-04-01 → 2021-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥-10.48 | 2019-04-01 → 2020-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥-35.6 | 2018-04-01 → 2019-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥17.8 | 2017-04-01 → 2018-03-31d | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| Net assets per share | ¥47.88 | at 2022-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥48.22 | at 2021-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥44.32 | at 2020-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥76.12 | at 2019-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Net assets per share | ¥55.37 | at 2018-03-31d | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 19.1% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 16.6% | at 2021-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 13.5% | at 2020-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 23.5% | at 2019-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 16.2% | at 2018-03-31d | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | 8.0% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 6.2% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -17.4% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | -55.1% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| ROE | 40.1% | 2017-04-01 → 2018-03-31d | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 5,034 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 5,641 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 6,498 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 7,640 | at 2019-03-31d | Cons. | Number of employees |
| Employees | 7,063 | at 2018-03-31d | Cons. | Number of employees |
| Revenue | ¥2.6bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥3.7bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥4.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.3bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.4bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥510m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | −¥622m | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | −¥499m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.1bn | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.3bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥2.6bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥158m | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.6bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.6bn | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | −¥1.4bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥1.6bn | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | −¥2.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥17.4bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥115m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥33.7bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥41.8bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥46.3bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥51.3bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥42.5bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥13.6bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥20.2bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥20.1bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥21.5bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥19.9bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥21.9bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥5.6bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.8bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.9bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-2.59 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.94 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.61 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-31.86 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.23 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥2.94 | 2020-04-01 → 2021-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥0.23 | 2017-04-01 → 2018-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥7.3 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥36.12 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥38.7 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥35.76 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥39.37 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥10.93 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 59.7% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.5% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.9% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.7% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 13.1% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -6.9% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.9% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -9.6% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | -126.8% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.8% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 556,218,400 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 556,218,400 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 556,218,400 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 556,218,400 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 254,872,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 217 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 225 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 333 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 380 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 284 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 41
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥1.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥1.7bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥774m |
| Beauty And Healthcarereportable segment | employees | at 2022-03-31 | 2643 pure |
| Beauty And Healthcarereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥44.8bn |
| Beauty And Healthcarereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥43.8bn |
| Beauty And Healthcarereportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥1.0bn |
| Beauty And Healthcarereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| Lifestylereportable segment | employees | at 2022-03-31 | 1066 pure |
| Lifestylereportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥84.4bn |
| Lifestylereportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥84.2bn |
| Lifestylereportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥177m |
| Lifestylereportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Platformreportable segment | employees | at 2022-03-31 | 1108 pure |
| Platformreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥34.9bn |
| Platformreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥34.4bn |
| Platformreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥532m |
| Platformreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1.8bn |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥164.1bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥162.4bn |
| —segment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥1.7bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥6.0bn |
| Reconciling Itemsreconciling | revenue | 2020-04-01 → 2021-03-31 | −¥1.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2020-04-01 → 2021-03-31 | −¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2020-04-01 → 2021-03-31 | −¥1.7bn |
| Beauty And Healthcarereportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥43.8bn |
| Beauty And Healthcarereportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥43.5bn |
| Beauty And Healthcarereportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥358m |
| Beauty And Healthcarereportable segment | segment profit | 2020-04-01 → 2021-03-31 | −¥216m |
| Lifestylereportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥91.8bn |
| Lifestylereportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥91.7bn |
| Lifestylereportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥151m |
| Lifestylereportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥4.1bn |
| Platformreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥34.2bn |
| Platformreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥33.5bn |
| Platformreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥754m |
| Platformreportable segment | segment profit | 2020-04-01 → 2021-03-31 | −¥565m |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥169.8bn |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥168.6bn |
| —segment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥1.3bn |
| —segment total | segment profit | 2020-04-01 → 2021-03-31 | ¥3.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,517
| Item | Context | Value | Unit |
|---|---|---|---|
| Equity instruments designated as measured at fair value through other comprehensive income dividend income IFRS | Prior1YearDuration | 4000000 | JPY |
| Equity instruments designated as measured at fair value through other comprehensive income dividend income IFRS | CurrentYearDuration | 16000000 | JPY |
| Other finance income IFRS | Prior1YearDuration | 25000000 | JPY |
| Other finance income IFRS | CurrentYearDuration | 17000000 | JPY |
| Finance income IFRS | Prior1YearDuration | 104000000 | JPY |
| Finance income IFRS | CurrentYearDuration | 71000000 | JPY |
| Financial liabilities measured at amortized cost interest expenses IFRS | Prior1YearDuration | 1786000000 | JPY |
| Financial liabilities measured at amortized cost interest expenses IFRS | CurrentYearDuration | 1469000000 | JPY |
| Other finance costs IFRS | Prior1YearDuration | 438000000 | JPY |
| Other finance costs IFRS | CurrentYearDuration | 306000000 | JPY |
| Finance costs IFRS | Prior1YearDuration | 2224000000 | JPY |
| Finance costs IFRS | CurrentYearDuration | 1775000000 | JPY |
| Gain on sale of fixed assets IFRS | Prior1YearDuration | 95000000 | JPY |
| Gain on sale of fixed assets IFRS | CurrentYearDuration | 1405000000 | JPY |
| Reversal of lease obligations IFRS IFRS | Prior1YearDuration | 1367000000 | JPY |
| Reversal of lease obligations IFRS IFRS | CurrentYearDuration | 1619000000 | JPY |
| Subsidy income from new coronavirus infection IFRS | Prior1YearDuration | 1399000000 | JPY |
| Subsidy income from new coronavirus infection IFRS | CurrentYearDuration | 1165000000 | JPY |
| Other other income IFRS | Prior1YearDuration | 1359000000 | JPY |
| Other other income IFRS | CurrentYearDuration | 860000000 | JPY |
| Other income IFRS | Prior1YearDuration | 4223000000 | JPY |
| Other income IFRS | CurrentYearDuration | 5050000000 | JPY |
| Impairment losses pl IFRS | Prior1YearDuration | 3308000000 | JPY |
| Impairment losses pl IFRS | CurrentYearDuration | 2023000000 | JPY |
| Loss on retirement of fixed assets IFRS | Prior1YearDuration | 242000000 | JPY |
| Loss on retirement of fixed assets IFRS | CurrentYearDuration | 129000000 | JPY |
| Loss due to new coronavirus infection IFRS | Prior1YearDuration | 2046000000 | JPY |
| Loss due to new coronavirus infection IFRS | CurrentYearDuration | 1278000000 | JPY |
| Other other expenses IFRS | Prior1YearDuration | 1393000000 | JPY |
| Other other expenses IFRS | CurrentYearDuration | 990000000 | JPY |
| Other expenses IFRS | Prior1YearDuration | 6990000000 | JPY |
| Other expenses IFRS | CurrentYearDuration | 4422000000 | JPY |
| Cash and deposits | Prior1YearInstant_NonConsolidatedMember | 4932000000 | JPY |
| Cash and deposits | CurrentYearInstant_NonConsolidatedMember | 2841000000 | JPY |
| Accounts receivable trade | Prior1YearInstant_NonConsolidatedMember | 2779000000 | JPY |
| Accounts receivable trade | CurrentYearInstant_NonConsolidatedMember | 3408000000 | JPY |
| Supplies | Prior1YearInstant_NonConsolidatedMember | 14000000 | JPY |
| Supplies | CurrentYearInstant_NonConsolidatedMember | 11000000 | JPY |
| Prepaid expenses | Prior1YearInstant_NonConsolidatedMember | 249000000 | JPY |
| Prepaid expenses | CurrentYearInstant_NonConsolidatedMember | 229000000 | JPY |
| Short term loans receivable | Prior1YearInstant_NonConsolidatedMember | 17006000000 | JPY |
| Short term loans receivable | CurrentYearInstant_NonConsolidatedMember | 11972000000 | JPY |
| Advances paid | Prior1YearInstant_NonConsolidatedMember | 563000000 | JPY |
| Advances paid | CurrentYearInstant_NonConsolidatedMember | 432000000 | JPY |
| Accounts receivable other | Prior1YearInstant_NonConsolidatedMember | 173000000 | JPY |
| Accounts receivable other | CurrentYearInstant_NonConsolidatedMember | 406000000 | JPY |
| Income taxes receivable | Prior1YearInstant_NonConsolidatedMember | 487000000 | JPY |
| Income taxes receivable | CurrentYearInstant_NonConsolidatedMember | 149000000 | JPY |
| Other ca | Prior1YearInstant_NonConsolidatedMember | 78000000 | JPY |
| Other ca | CurrentYearInstant_NonConsolidatedMember | 135000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 21 of 21 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |